Efficacy and safety of remimazolam tosylate for sedation during upper gastrointestinal endoscopy: study protocol for a multicenter randomized controlled trial
This study aims to describe the efficacy and safety of remimazolam tosylate as a sedative for upper gastrointestinal endoscopy.MethodsA multicenter, randomized, single-blind, parallel-controlled, noninferiority clinical study will be conducted to evaluate the efficacy and safety of remimazolam tosylate as a sedative during upper gastrointestinal endoscopy. Participants (n = 1800) will be randomized to receive remimazolam tosylate at 0.15 mg/kg (experimental group 1), remimazolam tosylate at 0.2 mg/kg (experimental group 2), or propofol at 1.5 mg/kg (control group). Procedure success will be assessed and defined as the comp...
Source: Trials - December 12, 2022 Category: Research Source Type: clinical trials
Holographic Screens as a Replacement of Monitors During GI Endoscopies
Condition: Gastrointestinal Diseases Intervention: Device: Endoscopy guided by mixed reality (HoloLens2TM) (UnlimiX™ software) Sponsors: Instituto Ecuatoriano de Enfermedades Digestivas; EndoscopyNet, Quito, Ecuador; mdconsgroup, Guayaquil, Ecuador Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2022 Category: Research Source Type: clinical trials
